Cover Image
Market Research Report
Product code 
993947

Preimplantation Genetic Testing

Published: | Global Industry Analysts, Inc. | 220 Pages | Delivery time: 1-2 business days

Price

Back to Top
Preimplantation Genetic Testing
Published: April 1, 2021
Global Industry Analysts, Inc.
Content info: 220 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Abstract:

Global Preimplantation Genetic Testing Market to Reach $775.1 Million by 2027

Amid the COVID-19 crisis, the global market for Preimplantation Genetic Testing estimated at US$434.6 Million in the year 2020, is projected to reach a revised size of US$775.1 Million by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$408.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $128.7 Million, While China is Forecast to Grow at 8% CAGR

The Preimplantation Genetic Testing market in the U.S. is estimated at US$128.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$134.4 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.

Software & Services Segment to Record 8.3% CAGR

In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 8.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$72.9 Million in the year 2020 will reach a projected size of US$128 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$89.4 Million by the year 2027.

Select Competitors (Total 34 Featured) -

  • Ariosa Diagnostics
  • Bioarray S.L.
  • California Pacific Medical Center (CPMC)
  • CombiMatrix
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Gene Technology
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • Reprogenetics
  • RHS Ltd.
  • Sequenom
  • Thermo Fisher Scientific, Inc.
Product Code: MCP22620

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Maternity Centers & Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Next Generation Sequencing (NGS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 34: USA Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 43: Canada Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Canada 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 52: Japan Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 58: Japan Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Japan Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Japan 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 61: China Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 64: China Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 67: China Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: China Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: China 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 70: Europe Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Europe 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 82: France Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 85: France Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 88: France Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: France Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: France 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 91: Germany Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 94: Germany Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 97: Germany Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Germany Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Germany 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 100: Italy Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 103: Italy Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 106: Italy Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Italy Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Italy 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 109: UK Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 112: UK Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 115: UK Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: UK Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: UK 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 118: Rest of Europe Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Rest of Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Rest of Europe 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 121: Rest of Europe Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Rest of Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Rest of Europe 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 124: Rest of Europe Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Rest of Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Rest of Europe 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 127: Asia-Pacific Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Asia-Pacific 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 130: Asia-Pacific Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Asia-Pacific Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Asia-Pacific 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 133: Asia-Pacific Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Asia-Pacific 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 136: Rest of World Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of World Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of World 15-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 139: Rest of World Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of World Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of World 15-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2012, 2020 & 2027
    • TABLE 142: Rest of World Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Rest of World Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Rest of World 15-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 34